Skip to main content
FinSpry Logo
FinSpry
BCAX logo
BCAX
(NASDAQ)
Bicara Therapeutics Inc.
$21.47-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Bicara Therapeutics (BCAX) Stock Price & Financial Analysis

Bicara Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.92 - $21.50
52-Week High$21.05
52-Week Low$7.80
Open$20.20
Volume919.78K
Average Volume (3M)919.78K
Market Cap1.17B
Shares Outstanding54.56M
Price to Book (P/B)2.78
EV/EBITDA-6.73
50-Day MA$17.34
200-Day MA$14.86
52-Week Change61.93%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Bicara Therapeutics

What is the current stock price for BCAX?

As of the latest trading session, BCAX stock trades at $21.47. The 52-week range is $7.80–$21.05, with a day range of $19.92–$21.50.

What is the P/E ratio for BCAX?

The P/E ratio (Price-to-Earnings) for BCAX is shown in the Key Statistics section. This valuation metric helps compare Bicara Therapeutics Inc. to industry peers.

Does BCAX pay dividends?

Bicara Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BCAX?

Based on 13 analysts, the consensus for BCAX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BCAX?

Bicara Therapeutics's market capitalization is $1.17B, classifying it as a small-cap company. Bicara Therapeutics operates in the Healthcare sector within the Biotechnology industry.